KDL Global

KDL Global is a Chinese brand operating in the medical consumables sector. The brand is associated with products such as medical consumables, surgical gloves, syringes, and wound dressings. Its official website is kdl-global.com. The available evidence identifies KDL Global as a medical consumable brand, covering categories including surgical glove brands, syringe brands, and wound dressing brands. As a China-based brand, it participates in the healthcare equipment and supplies market, specifically within medical consumables. Further details about its founding, ownership, and operations are not provided in the current evidence.

The available evidence does not provide a detailed history of KDL Global. The brand is identified as a Chinese medical consumable brand, with product categories including surgical gloves, syringes, and wound dressings. No founding date, ownership changes, or key historical milestones are documented in the current evidence.

• Medical consumables

  General category of medical consumable products.

• Surgical gloves

  Surgical glove products.

• Syringes

  Syringe products.

• Wound dressings

  Wound dressing products.

• 2022

  Disclosure violations draw SSE criticism; syringes hit with US FDA import alert

  In December 2022, the Shanghai Stock Exchange publicly criticized Kangdelai and then-board secretary Gu Jiajun for failing to timely disclose commitments related to a subsidiary's control, major asset restructuring procedures and other delayed disclosures; in 2023 the company was again subject to regulatory measures over disclosure issues. In May 2024, the US FDA issued an import alert on plastic syringes made by Kangdelai, recommending that US medical institutions stop using the China-made syringes. The disciplinary action was recorded in integrity files; exports of the company's syringes to the US market were blocked.

  Source

Read more

1. 1Disclosure violations draw SSE criticism; syringes hit with US FDA import alertnbd.com.cn
2. 2Disclosure violations draw SSE criticism; syringes hit with US FDA import alertfinance.cnr.cn